CLDF Title
Contact Us | Bookmark
About CLDF Centers of Educational Expertise  
Live CME Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
Banner2 Banner4 Banner3
  Liver News - REUTERS   Congress Calendar   Physician Resources  
New drug shows promise against anemia of inflammation
Triptolide nanoformulation targets liver cancer cells
Even if you build a toilet, they may not come - water expert
New index helps predict course of early HCV cirrhosis
View Complete News Library
September 19-20
GALA (GI and Liver Association of the Americas) Conference
San Francisco, California
October 17-22, 2014
American College of Gastroenterology (ACG)
Philadelphia, PA
November 7-11
The Liver Meeting 2014
Boston, MA
View all Congresses
  Featured Abstracts          
Vaniprevir plus peginterferon alfa-2a and ribavirin in treatment-experienced Japanese patients with hepatitis C virus genotype 1 infection: a randomized phase II study
Safety, pharmacokinetics and pharmacodynamics of the oral Toll-like receptor 7 agonist GS-9620 in treatment-naive patients with chronic hepatitis C
The pharmacokinetics of daclatasvir and asunaprevir administered in combination in studies in healthy subjects and patients infected with hepatitis c virus
Treatment of hepatitis C: a systematic review
Ending hepatitis C in the United States: the role of screening
Effectiveness of Telaprevir and Boceprevir Triple Therapy for Patients with Hepatitis C Virus Infection in a Large Integrated Care Setting
Efficacy of Entecavir plus Tenofovir Combination Therapy for Chronic Hepatitis B Patients with Multi-Drug Resistant Strains
Entecavir Is Safe and Effective in Patients Previously Treated with Adefovir, including Those with Adefovir-Resistance
Assessment of Bone Mineral Density in Tenofovir treated Chronic Hepatitis B patients: Can FRAX identify those at greatest risk?
Immunogenicity of hepatitis B vaccine in patients with inflammatory bowel disease and the benefits of revaccination
Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: A randomized controlled trial
Confounders in the detection of minimal hepatic encephalopathy: a neuropsychological and quantified EEG study
Disrupted small world networks in patients without overt hepatic encephalopathy: A resting state fMRI study
Brain oscillatory activity during sleep shows unknown dysfunctions in early encephalopathy
Racial Differences in the Progression to Cirrhosis and Hepatocellular Carcinoma in HCV-Infected Veterans
Serum autoantibody measurement for the detection of hepatocellular carcinoma
The combination of TACE (transcatheter arterial chemombolization) and sorafenib is well-tolerated and effective in Asian Patients with hepatocellular carcinoma: Final results of the START trial
Modelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality
          View All Abstracts  
Slide Library
Abstract Library
Live CME Meetings
Slide Library
Abstract Library
Slide Library
Abstract Library
Live CME Meetings
Slide Library
Abstract Library
CLDF Follow Us
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of
Educational Expertise
Regional Map
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.